Radiofrequency Renal Denervation: The Next Frontier for Difficult-to-Control Hypertension
November 03, 2023 | 06:45 AM - 07:45 AM
Location: Grand Ballroom Salon I, Level 5, Philadelphia Marriott Downtown
Hypertension is highly prevalent in the US population, with worsening rates of blood pressure control over time. In particular, approximately 20% of patients with hypertension have apparent treatment-resistant hypertension, requiring four or more antihypertensive medications to achieve adequate blood pressure control. Many patients with apparent treatment-resistant hypertension are nonadherent to antihypertensive therapy, which can be a major contributor to inadequate blood pressure control. Although renal denervation is not for every patient, there are many patients who may benefit from it. Furthermore, more patients than many providers realize are interested in pursuing renal denervation if it is offered to them.
This symposium provides an overview of the mechanisms of radiofrequency renal denervation, updates on the most recent literature surrounding radiofrequency renal denervation, best approaches to identifying optimal candidates for renal denervation, and practical insights into how to set up a renal denervation program.
Support is provided by an educational grant from Medtronic.
- Discuss underlying mechanisms and up-to-date data on the safety and efficacy of contemporary approaches to radiofrequency renal denervation for the management of difficult to control hypertension
- Identify appropriate patients to undergo renal denervation
- Determine the optimal approach to successfully establishing and building a renal denervation program
- Hypertension and Cardiorenal Disorders
06:45 AM - 06:55 AM
- Interpreting the Renal Denervation Literature: Mechanisms, Safety, and Effectiveness
06:55 AM - 07:15 AM
- Practical Approaches to Renal Denervation: Establishing a Program and Optimizing Patient Selection
07:15 AM - 07:35 AM
- Audience Q&A
07:35 AM - 07:45 AM